Alpha Cognition Inc. Common Stock earnings per share and revenue
On Nov 13, 2025, ACOG reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.43 USD, resulting in a 81.76% surprise. Revenue reached 2.84 million, compared to an expected 2.07 million, with a 37.03% difference. The market reacted with a -3.10% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
FAQ
What were Alpha Cognition Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Alpha Cognition Inc. Common Stock reported EPS of -$0.08, beating estimates by 81.76%, and revenue of $2.84M, 37.03% above expectations.
How did the market react to Alpha Cognition Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.1%, changed from $6.13 before the earnings release to $5.94 the day after.
When is Alpha Cognition Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Alpha Cognition Inc. Common Stock's next earnings report?
Based on --
analysts, Alpha Cognition Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.